Back
Processa Pharmaceuticals 10K Form
Sell
13
PCSA
Processa Pharmaceuticals
Last Price:
1.93
Seasonality Move:
40.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PCSA News And Ratings
See the #1 stock for the next 7 days that we like better than PCSA
PCSA Financial Statistics
Sales & Book Value
| Annual Sales: | $5K |
|---|---|
| Cash Flow: | $-2.05M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.11 |
| Price / Book: | 0.63 |
Profitability
| EPS (TTM): | -6.39000 |
|---|---|
| Net Income (TTM): | $-9.83M |
| Gross Margin: | $5K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Processa Pharmaceuticals Earnings Forecast
Key Processa Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 5 years for PCSA is 100.00%.
- The Selling, General & Administrative Expenses for PCSA have been equal to 1,399.40% of Gross Profit Margin.
- The Interest Expense is -1.95% of Operating Income.
- Per Share Earnings over the last 12 years have been positive in 7 years.
Processa Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PCSA |
| Website: | processapharmaceuticals.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PCSA Technical Analysis vs Fundamental Analysis
Sell
13
Processa Pharmaceuticals (PCSA)
is a Sell
Is Processa Pharmaceuticals a Buy or a Sell?
-
Processa Pharmaceuticals stock is rated a Sell
The current Processa Pharmaceuticals [PCSA] share price is $1.96. The Score for PCSA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.